Accessibility Menu
Plandaí Biotechnology logo

Plandaí Biotechnology(OTC) PLPL

Market Cap$44.90KMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2011)-100%
5 Year-100%
1 Year+0%
1 Month+0%
$0.00
+0.00%
+0.00Today
Plandaí Biotechnology last closing stock price
MetricPriceDate
Last closeUSD 0.002026-08-04
Plandaí Biotechnology stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+0%USD 0.002026-07-28
1 month+0%USD 0.002026-07-02
3 month+0%USD 0.002026-05-01
Year to date-99%USD 0.002025-12-31
1 year+0%USD 0.002025-07-31
3 year-99.5%USD 0.002023-08-04
5 year-99.86%USD 0.002021-08-05
Since inception-100%USD 0.212011-11-18

Plandaí Biotechnology Financials at a Glance

Market Cap

$44.90KMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$0.00

Net Income (TTM)

-$60.13K

EPS (TTM)

$0.00

P/E Ratio

0.00

Dividend

$0.00

Beta (Volatility)

54.79 (High)

Price

$0.00

Volume

20,049

Open

$0.00

Previous Close

$0.00

Daily Range

$0.00 - $0.00

52-Week Range

$0.00 - $0.00

Estimated Earnings Date

N/A

PLPL News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Plandaí Biotechnology

Plandaí Biotechnology, Inc. focuses on developing unique botanical extracts for the nutraceutical and pharmaceutical sectors. The company is known for its Phytofare Catechin Complex, derived from green tea, and is expanding its product line with various botanical extracts.

Products and Services
  • Phytofare Catechin Complex from green tea
  • Phytofare citrus complex and tomato fruit extracts
  • Botanical extracts from Artemisia and cannabis
Growth Outlook
  • Expansion into nutraceutical markets presents significant opportunities
  • Development of diverse botanical extracts enhances product portfolio
  • Strategic agricultural operations in South Africa support growth
Financial Highlights
  • Recent quarterly net income of -$849, indicating ongoing investment in R&D
  • Trailing twelve months show a consistent focus on product development
  • Market capitalization of approximately $448,895 reflects potential for growth
Plandaí Biotechnology, Inc. is positioned in a niche market with a focus on innovative botanical extracts. The company's commitment to research and development is evident in its financials, which show ongoing investments despite current losses. The strategic agricultural operations in South Africa not only support product development but also provide a unique advantage in sourcing raw materials. As the nutraceutical and pharmaceutical industries continue to grow, Plandaí's diverse product offerings and focus on botanical extracts may present significant opportunities for future expansion and profitability.
AI Generated • Jul 28, 2026

Industry

Biotechnology

Sector

Health Care

CEO

Yi-Kuan Lin

Website

www.diamondranchfoods.com

Headquarters

Taipei, TP W1S 1BN, TW

PLPL Financials

Key Financial Metrics (TTM)

Gross Margin

0.00%

Operating Margin

0.00%

Net Income Margin

0.00%

Return on Equity

0.00%

Return on Capital

-57.45%

Return on Assets

0.00%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$44.90KMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

44.89B

Volume

20.05K

Avg. Volume

1.42M

Financials (TTM)

Gross Profit

$0.00

Operating Income

-$60.04K

EBITDA

-$60.04K

Operating Cash Flow

$15.64M

Capital Expenditure

-$3.12

Free Cash Flow

$15.64M

Cash & ST Invst.

$0.00

Total Debt

$158.78K

Plandaí Biotechnology Performance Analysis

Plandaí Biotechnology annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-06-30USD 0N/A
20232023-06-30USD 0N/A
20242024-06-30USD 0N/A
20252025-06-30USD 0N/A
Plandaí Biotechnology sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q42025-06-30N/A
Q12025-09-30N/A
Q22025-12-31N/A
Q32026-03-31N/A
Plandaí Biotechnology annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-06-30USD 0.00N/A
20232023-06-30USD -0.00N/A
20242024-06-30USD 0.00N/A
20252025-06-30USD 0.00N/A
Plandaí Biotechnology sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q42025-06-30N/A
Q12025-09-30N/A
Q22025-12-31N/A
Q32026-03-31N/A

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q3 2025YOY CHG

Revenue

$0.00

N/A

Gross Profit

$0.00

N/A

Gross Margin

0.00%

N/A

Market Cap

$44.90KMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$249.44

N/A

Employees

180

N/A

Net Income

-$849.00

+94.9%

EBITDA

-$803.00

+95.2%

Quarterly Fundamentals

Name
Q3 2025YOY CHG

Total Cash

$0.00

N/A

Total Debt

$158.78K

+216.5%

Accounts Receivable

$0.00

N/A

Inventory

$0.00

N/A

Long Term Debt

$100.00K

N/A

Short Term Debt

$58.78K

+17.1%

Return on Assets

0.00%

N/A

Return on Invested Capital

0.00%

N/A

Free Cash Flow

$15.82M

+3858041.2%

Operating Cash Flow

$15.82M

+3858042.2%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
CBTCXTRA Bitcoin Inc.
$0.00-25.00%
AGSSAmeriguard Security Services, Inc.
$0.01+0.00%
FUNRFunr
$0.00+0.00%
SVADSilverton Adventures, Inc.
$0.00+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
EAElectronic Arts
$209.70-0.00%
SPCXSpace Exploration Technologies
$125.33+0.09%
TQQQProShares Trust - ProShares UltraPro Qqq
$74.82+0.10%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$8.07+0.03%

Questions About PLPL

What is the current price of Plandaí Biotechnology?

Plandaí Biotechnology is trading at $0.00 per share.

What is the 52-week range for Plandaí Biotechnology?

Over the past 52 weeks, Plandaí Biotechnology has traded between $0.00 and $0.00.

How much debt does Plandaí Biotechnology have?

As of the most recent reporting period, Plandaí Biotechnology reported total debt of $95.62K.

How much cash does Plandaí Biotechnology have on hand?

Plandaí Biotechnology reported $0.00 in cash and cash equivalents in its most recent financial results.

What is Plandaí Biotechnology’s dividend yield?

Plandaí Biotechnology does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services